S-verapamil
Alternative Names: D 2024; levoverapamilLatest Information Update: 24 Sep 2007
At a glance
- Originator Celltech R&D
- Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Coronary disorders; Hypertension
Most Recent Events
- 08 Oct 2001 No-Development-Reported for Angina pectoris in United Kingdom (Unknown route)
- 08 Oct 2001 No-Development-Reported for Arrhythmias in United Kingdom (Unknown route)
- 08 Oct 2001 No-Development-Reported for Coronary disorders in United Kingdom (Unknown route)